On the pre-clinical validation of a commercial model-based optimisation engine: Application to volumetric modulated arc therapy for patients with lung or prostate cancer

Radiotherapy and Oncology

Volumn 113, Issue 3, 2014, Pages 385-391

  Fogliata, Antonella ^a   Belosi, Francesca ^a   Clivio, Alessandro ^a   Navarria, Piera ^b   Nicolini, Giorgia ^a   Scorsetti, Marta ^b   Vanetti, Eugenio ^a   Cozzi, Luca ^a  

^a ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Knowledge based planning; Locally advanced lung cancer; Low risk prostate cancer; RapidArc; RapidPlan

Indexed keywords

ADVANCED CANCER; ARTICLE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PROCESS OPTIMIZATION; PROSTATE CANCER; RADIATION DOSE; RADIOTHERAPY PLANNING SYSTEM; TREATMENT PLANNING; VALIDATION PROCESS; COMPUTER ASSISTED RADIOTHERAPY; LUNG NEOPLASMS; PROCEDURES; PROSTATIC NEOPLASMS; RADIOMETRY; RISK; VALIDATION STUDY;

HUMANS; LUNG NEOPLASMS; MALE; PROSTATIC NEOPLASMS; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RISK;

EID: 84915779370     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2014.11.009     Document Type: Article

References (18)

1. V. Chanyavanich, S. Das, W. Lee, and W. Lo Knowledge based IMRT treatment planning for prostate cancer Med Phys 38 2011 2515 2522
2. X. Zhu, Y. Ge, T. Li, D. Thongphiew, F.F. Yin, and J. Wu A planning quality evaluation tool for prostate adaptive IMRT based on machine learning Med Phys 38 2011 719 726
3. L. Yuan, Y. Ge, W. Lee, F.F. Yin, J. Kirkpatrick, and J. Wu Quantitative analysis of the factors which affect the inter-patient organ-at risk dose sparing variation in IMRT plans Med Phys 39 2012 6868 6878
4. J. Lian, L. Yuan, Y. Ge, B. Chera, D. Yoo, and S. Chang Modeling the dosimetry of organ-at-risk in head and neck IMRT planning: an inter-technique and inter-institutional study Med Phys 40 2013 121704
5. D. Good, J. Lo, R. Lee, J. Wu, F.F. Yin, and S. Das A knowledge based approach to improving and homogenizing intensity modulated radiation therapy planning quality among treatment centers: an example application to prostate cancer planning Int J Radiat Oncol Biol Phys 87 2013 176 181
6. K. Moore, R. Scott Brame, D. Low, and S. Mutic Experience based quality control of clinical intensity modulated radiotherapy planning Int J Radiat Oncol Biol Phys 81 2011 545 551
7. L. Appenzoller, J. Michalski, W. Thorstad, S. Mutic, and K. Moore Predicting dose-volume histograms for organs-at-risk in IMRT planning Med Phys 39 2012 7446 7461
8. E. Quan, J. Chang, Z. Liao, T. Xia, Z. Yuan, and H. Liu Automated volumetric modulated arc therapy treatment planning for stage III lung cancer: how does it compare with intensity-modulated radio therapy? Int J Radiat Oncol Biol Phys 84 2012 e69 e76
9. Z. Xiaodong, L. Xiaoqiang, M. Enzhuo, P. Xiaoning, and L. Yupeng A methodology for automatic intensity-modulated radiation treatment planning for lung cancer Phys Med Biol 56 2012 3873
10. J. Agapito On the possible benefits of a hybrid VMAT technique in the treatment of non-small cell lung cancer Med Dosim 38 2013 460 466
11. I. Bree, M. van Hinsberg, and L. van Veelen High dose radiotherapy in inoperable non small cell lung cancer: comparison of volumetric modulated arc therapy, dynamic IMRT and 3D conformal radiotherapy Med Dosim 37 2012 353 357
12. C. Merrow, I. Wang, and M. Podgorsak A dosimetric evaluation of VMAT for the treatment of non-small cell lung cancer J Appl Clin Med Phys 14 2013 4110
13. L. Persoon, A. Egelmeer, M. Ollers, S. Nijsten, E. Troost, and F. Verhagen First clinical results of adaptive radiotherapy based on 3D portal dosimetry for lung cancer patients with atelectasis treated with volumetric modulated arc therapy (VMAT) Acta Oncol 52 2013 1484 1489
14. M. Scorsetti, P. Navarria, P. Mancosu, F. Alongi, S. Castiglioni, and R. Cavina Large volume unresectable locally advanced non-small cell lung cancer: acute toxicity and initial outcome results with rapid arc Radiat Oncol 5 2010 94
15. M. Aznar, P. Petersen, A. Logadottir, H. Lindberg, S. Korreman, and F. Kjaer-Kristoffersen Rotational radiotherapy for prostate cancer in clinical practice Radiother Oncol 97 2010 480 484
16. D. Poon, M. Kam, C. Leung, R. Chau, S. Wong, and W.Y. Lee Dosimetric advantages and superior treatment delivery efficiency of Rapidarc over conventional intensity-modulated radiotherapy in high-risk prostate cancer involving seminal vesicles and pelvic nodes Clin Oncol (R Coll Radiol) 25 2013 706 712
17. F. Alongi, A. Fogliata, P. Navarria, A. Tozzi, P. Mancosu, and F. Lobefalo Moderate hypofractionation and simultaneous integrated boost with volumetric modulated arc therapy (RapidArc) for prostate cancer. Report of feasibility and acute toxicity Strahlenther Onkol 188 2012 990 996
18. A. Fogliata, P.-M. Wang, F. Belosi, A. Clivio, G. Nicolini, and E. Vanetti Assessment of a model based optimization engine for volumetric modulated ar therapy for patients with advanced hepatocellular cancer Radiat Oncol 9 2014 236